Research graph
References from An update to the classification, evaluation, and management of childhood interstitial lung disease in infancy: an official American Thoracic Society Clinical Practice Guideline. Local targets link to admitted publications; unresolved targets remain external evidence.
Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade’s experience
10.1186/s13023-017-0637-x · 2017 · External reference
International management platform for children’s interstitial lung disease (chILD-EU)
10.1136/thoraxjnl-2017-210519 · 2018 · External reference
Incidence and prevalence of children’s diffuse lung disease in Spain
10.1016/j.arbres.2021.06.001 · 2022 · External reference
A national internet-linked based database for pediatric interstitial lung diseases: the French network
10.1186/1750-1172-7-40 · 2012 · External reference
The US national registry for childhood interstitial and diffuse lung disease: report of study design and initial enrollment cohort
10.1002/ppul.26568 · 2024 · External reference
Etiologic classification of diffuse parenchymal (interstitial) lung diseases
10.3390/jcm11061747 · 2022 · External reference
Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the chILD classification scheme
10.1513/annalsats.201501-064oc · 2015 · External reference
Diffuse lung disease in young children: application of a novel classification scheme
10.1164/rccm.200703-393oc · 2007 · External reference
Epidemiology of childhood interstitial lung disease in France: the RespiRare cohort
10.1136/thorax-2023-221325 · 2024 · External reference
Childhood interstitial lung disease survivors in adulthood: a European collaborative study
10.1183/13993003.00680-2024 · 2025 · External reference
An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy
10.1164/rccm.201305-0923st · 2013 · External reference
Postinfectious bronchiolitis obliterans in children: case series at a pediatric hospital in Peru
10.24875/bmhim.23000045 · 2023 · External reference
Genotype-phenotype correlations for infants and children with ABCA3 deficiency
10.1164/rccm.201402-0342oc · 2014 · External reference
Lung disease caused by ABCA3 mutations
10.1136/thoraxjnl-2016-208649 · 2017 · External reference
Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients
10.1183/09031936.00129414 · 2015 · External reference
Nintedanib in children and adolescents with fibrosing interstitial lung diseases
10.1183/13993003.01512-2022 · 2023 · External reference
Biallelic mutations of methionyl-tRNA synthetase cause a specific type of pulmonary alveolar proteinosis prevalent on reunion island
10.1016/j.ajhg.2015.03.010 · 2015 · External reference
Systemic inflammatory syndrome in children with FARSA deficiency
10.1111/cge.14120 · 2022 · External reference
A dominant negative variant of RAB5B disrupts maturation of surfactant protein B and surfactant protein C
10.1073/pnas.2105228119 · 2022 · External reference
Human inherited CCR2 deficiency underlies progressive polycystic lung disease
10.1016/j.cell.2024.05.021 · 2024 · External reference
Bi-allelic LAMP3 variants in childhood interstitial lung disease: a surfactant-related disease
10.1016/j.ebiom.2025.105626 · 2025 · External reference
The GRADE approach and Bradford Hill’s criteria for causation
10.1136/jech.2010.119933 · 2011 · External reference
Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations
10.1111/j.1398-9995.2010.02530.x · 2011 · External reference
Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs
10.1016/j.lanwpc.2020.100001 · 2020 · External reference
Use of ultra-rapid whole-exome sequencing to diagnose congenital central hypoventilation syndrome
10.1002/ppul.24686 · 2020 · External reference
Rapid whole-exome sequencing as a diagnostic tool in a neonatal/pediatric intensive care unit
10.3390/jcm9072220 · 2020 · External reference
Rapid resolution of blended or composite multigenic disease in infants by whole-exome sequencing
10.1016/j.jpeds.2016.12.032 · 2017 · External reference
Mutations in the surfactant protein C gene associated with interstitial lung disease
10.1378/chest.121.3_suppl.20s · 2002 · External reference
Infants with atypical presentations of alveolar capillary dysplasia with misalignment of the pulmonary veins who underwent bilateral lung transplantation
10.1016/j.jpeds.2017.10.026 · 2018 · External reference
The spectrum of interstitial lung disease in childhood
10.1002/ppul.1950262329 · 2001 · External reference
Genetic testing utilization in the U.S. registry for childhood interstitial and diffuse lung diseases
10.1002/ppul.71073 · 2025 · External reference
ABCA3 gene mutations in newborns with fatal surfactant deficiency
10.1056/nejmoa032178 · 2004 · External reference
Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
10.1186/1750-1172-4-26 · 2009 · External reference
Childhood interstitial lung diseases: an 18-year retrospective analysis
10.1542/peds.2013-1780 · 2013 · External reference
Genetic basis for childhood interstitial lung disease among Japanese infants and children
10.1038/pr.2017.217 · 2018 · External reference
The role of exome sequencing in childhood interstitial or diffuse lung disease
10.1186/s13023-022-02508-1 · 2022 · External reference
ABCA3 mutations associated with pediatric interstitial lung disease
10.1164/rccm.200503-504oc · 2005 · External reference
Lung biopsies in infants and children in critical care situation
10.1002/ppul.26845 · 2024 · External reference
Utility of open surgical lung biopsy in children
10.1016/j.pupt.2019.101816 · 2019 · External reference
Lung biopsy in children’s interstitial and diffuse lung disease: does it alter management?
10.1002/ppul.24683 · 2020 · External reference
Clinical relevance of rapid FOXF1-targeted sequencing in patients suspected of alveolar capillary dysplasia with misalignment of pulmonary veins
10.1016/j.labinv.2023.100233 · 2023 · External reference
A morphomolecular approach to alveolar capillary dysplasia
10.1016/j.ajpath.2022.05.004 · 2022 · External reference
Fast detection of FOXF1 variants in patients with alveolar capillary dysplasia with misalignment of pulmonary veins using targeted sequencing
10.1038/s41390-020-0931-5 · 2021 · External reference
Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations
10.1016/j.ajhg.2009.05.005 · 2009 · External reference
Two deletions overlapping a distant FOXF1 enhancer unravel the role of lncRNA LINC01081 in etiology of alveolar capillary dysplasia with misalignment of pulmonary veins
10.1002/ajmg.a.36606 · 2014 · External reference
Novel FOXF1 mutations in sporadic and familial cases of alveolar capillary dysplasia with misaligned pulmonary veins imply a role for its DNA binding domain
10.1002/humu.22313 · 2013 · External reference
Incidence of alveolar capillary dysplasia with misalignment of pulmonary veins in infants with unexplained severe pulmonary hypertension: the roles of clinical, pathological, and genetic testing
10.1016/j.earlhumdev.2021.105323 · 2021 · External reference
Phenotypic and genetic spectrum of alveolar capillary dysplasia: a retrospective cohort study
10.1136/archdischild-2019-317121 · 2020 · External reference
Familial interstitial disease with I73T mutation: a mid- and long-term study
10.1002/ppul.20970 · 2009 · External reference
Characteristics of disorders associated with genetic mutations of surfactant protein C
10.1136/adc.2009.171553 · 2010 · External reference
Clinical, radiological and pathological features of ABCA3 mutations in children
10.1136/thx.2007.083766 · 2008 · External reference
Ground glass and fibrotic change in children with surfactant protein C dysfunction mutations
10.1002/ppul.25356 · 2021 · External reference
ABCA3-related interstitial lung disease beyond infancy
10.1136/thorax-2022-219434 · 2023 · External reference
Inherited pulmonary surfactant metabolism disorders in Argentina: differences between patients with SFTPC and ABCA3 variants
10.1002/ppul.26225 · 2023 · External reference
Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency
10.1126/sciimmunol.abf9564 · 2021 · External reference
Heterogeneity of lung disease associated with NK2 homeobox 1 mutations
10.1016/j.rmed.2017.05.014 · 2017 · External reference
Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1
10.1378/chest.12-2502 · 2013 · External reference
Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis
10.1186/s13023-014-0171-z · 2014 · External reference
Clinical and genetic spectrum of interstitial lung disease in Chinese children associated with surfactant protein C mutations
10.1186/s13052-019-0710-2 · 2019 · External reference
Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations
10.1038/ejhg.2015.45 · 2015 · External reference
Genetic testing in children with surfactant dysfunction
10.1136/archdischild-2012-303166 · 2013 · External reference
Surfactant protein B deficiency: the RespiRare cohort
10.1136/thorax-2024-221947 · 2025 · External reference
Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children
10.1093/hmg/ddr508 · 2012 · External reference
New surfactant protein C gene mutations associated with diffuse lung disease
10.1136/jmg.2009.066829 · 2009 · External reference
A common mutation in the surfactant protein C gene associated with lung disease
10.1016/j.jpeds.2004.10.028 · 2005 · External reference
Analysis of 40 sporadic or familial neonatal and pediatric cases with severe unexplained respiratory distress: relationship to SFTPB
10.1002/ajmg.a.20058 · 2003 · External reference
Genetic basis of surfactant dysfunction in Chinese children: a retrospective study
10.1002/ppul.24334 · 2019 · External reference
Hereditary interstitial lung diseases manifesting in early childhood in Japan
10.1038/pr.2014.114 · 2014 · External reference
Novel variant findings and challenges associated with the clinical integration of genomic testing: an interim report of the genomic medicine for ill neonates and infants (GEMINI) study
10.1001/jamapediatrics.2020.5906 · 2021 · External reference
Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: a randomized clinical trial
10.1001/jamapediatrics.2021.3496 · 2021 · External reference
Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients
10.1016/j.jaip.2020.11.007 · 2021 · External reference
Efficacy and adverse events during Janus kinase inhibitor treatment of SAVI syndrome
10.1007/s10875-019-00645-0 · 2019 · External reference
Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management
10.1001/jamapediatrics.2017.3438 · 2017 · External reference
Integrating rapid exome sequencing into NICU clinical care after a pilot research study
10.1038/s41525-022-00326-9 · 2022 · External reference
Heterozygous mutations in the C-terminal domain of COPA underlie a complex autoinflammatory syndrome
10.1172/jci163604 · 2024 · External reference
Heterogeneous pulmonary phenotypes in filamin a mutation-related lung disease
10.1089/ped.2020.1280 · 2021 · External reference
STING-associated vasculopathy with onset in infancy in three children with new clinical aspect and unsatisfactory therapeutic responses to tofacitinib
10.1007/s10875-019-00690-9 · 2020 · External reference
Surfactant protein C dysfunction with new clinical insights for diffuse alveolar hemorrhage and autoimmunity
10.1002/ped4.12162 · 2019 · External reference
Childhood interstitial lung diseases: lessons learned from 15-year observation at a Polish referral center
10.1002/ppul.71112 · 2025 · External reference
Clinical scope and healthcare utilization in childhood interstitial lung disease at a tertiary center
10.1002/ppul.26600 · 2024 · External reference
Exome and whole genome sequencing in the neonatal intensive care unit
10.1016/j.clp.2021.11.018 · 2022 · External reference
Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency
10.1016/j.jaci.2020.08.022 · 2021 · External reference
Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)
10.1038/s41436-021-01242-6 · 2021 · External reference
Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency
10.1164/ajrccm.161.3.9903153 · 2000 · External reference
Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism
10.1016/j.jpeds.2017.01.017 · 2017 · External reference
Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions
10.1016/j.gim.2022.03.005 · 2022 · External reference
Project Baby Bear: rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of care
10.1016/j.ajhg.2021.05.008 · 2021 · External reference
Mortality of pediatric surgical lung biopsies in Ontario, Canada, 2000-2019
10.1513/annalsats.202304-306oc · 2024 · External reference
Lymphocytic interstitial pneumonia and follicular bronchiolitis in children: a registry-based case series
10.1002/ppul.24680 · 2020 · External reference
Phenotypic expansion of KMT2D-related disorder: beyond Kabuki syndrome
10.1002/ajmg.a.61518 · 2020 · External reference
Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life
10.1136/bmjresp-2021-001139 · 2022 · External reference
Ethical issues associated with direct-to-consumer genetic testing
10.7759/cureus.39918 · 2023 · External reference
Workplace genomic testing: what do company websites say about federal privacy and anti-discrimination laws?
10.1159/000546189 · 2025 · External reference
Child health and the pediatric pulmonology workforce: 2020-2040
10.1542/peds.2023-063678q · 2024 · External reference
The 2019 US medical genetics workforce: a focus on clinical genetics
10.1038/s41436-021-01162-5 · 2021 · External reference
Projecting the supply and demand for certified genetic counselors: a workforce study
10.1007/s10897-017-0158-8 · 2018 · External reference
The significance of multidisciplinary team meetings in diagnosing and managing childhood interstitial lung disease within the RespiRare network
10.1002/ppul.26765 · 2024 · External reference
Idiopathic pulmonary fibrosis with benign SFTPC variant and pathogenic MARS1 mutations: can’t see the forest for the trees!
10.1183/23120541.00472-2023 · 2023 · External reference
Using an experiment among clinical experts to determine the cost and clinical impact of rapid whole exome sequencing in acute pediatric settings
10.3389/fped.2023.1204853 · 2023 · External reference
Making a genetic diagnosis in a level IV neonatal intensive care unit population: who, when, how, and at what cost?
10.1016/j.jpeds.2019.05.054 · 2019 · External reference
Genetic testing for diffuse lung diseases in children
10.1002/ppul.26447 · 2024 · External reference
Clinical, functional, and computed tomography findings in a cohort of patients with neuroendocrine cell hyperplasia of infancy
10.1002/ppul.25319 · 2021 · External reference
Neuroendocrine cell hyperplasia of infancy: feasibility of objective evaluation with quantitative CT
10.1016/j.clinimag.2022.06.004 · 2022 · External reference
Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT
10.2214/ajr.09.2743 · 2010 · External reference
Ground-glass burden as a biomarker in neuroendocrine cell hyperplasia of infancy
10.1002/ppul.24301 · 2019 · External reference
Diagnostic criteria and follow-up in neuroendocrine cell hyperplasia of infancy: a case series
10.1590/s1806-37132013000500007 · 2013 · External reference
Long-term evolution of neuroendocrine cell hyperplasia of infancy: the FRENCHI findings
10.1007/s00431-022-04734-y · 2023 · External reference
French national cohort of neuroendocrine cell hyperplasia of infancy (FRENCHI) study: diagnosis and initial management
10.1007/s00431-022-04510-y · 2022 · External reference
Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism
10.1136/thx.2008.107979 · 2009 · External reference
Lung and airway shape in neuroendocrine cell hyperplasia of infancy
10.1007/s00247-018-4189-6 · 2018 · External reference
Familial neuroendocrine cell hyperplasia of infancy
10.1002/ppul.21219 · 2010 · External reference
Persistent tachypnea of infancy. Usual and aberrant
10.1164/rccm.201508-1655oc · 2016 · External reference
Surfactant protein C gene (SFTPC) mutation-associated lung disease: high-resolution computed tomography (HRCT) findings and its relation to histological analysis
10.1002/ppul.21289 · 2010 · External reference
High-resolution computed tomography findings of thyroid transcription factor 1 deficiency (NKX2-1 mutations)
10.1007/s00247-019-04388-3 · 2019 · External reference
Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children
10.1002/ppul.21080 · 2009 · External reference
Clinical profile and course of children with postinfectious bronchiolitis obliterans from a tertiary care hospital
10.4103/lungindia.lungindia_145_19 · 2020 · External reference
Bronchiolitis obliterans: clinical and radiological profile of children followed-up in a reference outpatient clinic
10.1590/s0103-05822013000100003 · 2013 · External reference
Lung clearance index and quantitative computed tomography of post-infectious bronchiolitis obliterans in infants
10.1038/s41598-017-15330-8 · 2017 · External reference
Clinical features of postinfectious bronchiolitis obliterans in children undergoing long-term nebulization treatment
10.1007/s12519-018-0193-z · 2018 · External reference
Post-infectious bronchiolitis obliterans in children: a review of 42 cases
10.1186/1471-2431-14-238 · 2014 · External reference
Clinical features of post-infectious bronchiolitis obliterans in children undergoing long-term azithromycin treatment
10.3892/etm.2015.2418 · 2015 · External reference
Clinical analysis and risk factors of bronchiolitis obliterans after mycoplasma pneumoniae pneumonia
10.2147/idr.s372940 · 2022 · External reference
Post-infectious bronchiolitis obliterans: can CT scan findings at early age anticipate lung function?
10.1002/ppul.21115 · 2010 · External reference
Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors
10.1159/000072900 · 2003 · External reference
Pulmonary alveolar proteinosis in children on La Reunion Island: a new inherited disorder?
10.1186/1750-1172-9-85 · 2014 · External reference
CT scan patterns of pulmonary alveolar proteinosis in children
10.1007/s002470050560 · 1999 · External reference
Primary pulmonary alveolar proteinosis: computed tomography features at diagnosis
10.1007/s00247-014-2888-1 · 2014 · External reference
Pulmonary interstitial glycogenosis: diagnostic evaluation and clinical course
10.1002/ppul.24123 · 2018 · External reference
Isolated pulmonary interstitial glycogenosis associated with alveolar growth abnormalities: a long-term follow-up study
10.1002/ppul.24324 · 2019 · External reference
High-resolution CT findings of pulmonary interstitial glycogenosis
10.1007/s00247-018-4138-4 · 2018 · External reference
Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAFV600E mutation study from the French national cohort
10.1016/j.humpath.2019.04.005 · 2019 · External reference
Outcome in children with pulmonary Langerhans cell Histiocytosis
10.1002/pbc.20112 · 2004 · External reference
Chest computed tomography findings for a cohort of children with pulmonary Langerhans cell histiocytosis
10.1002/pbc.28496 · 2020 · External reference
Pulmonary Langerhans cell histiocytosis: a variable disease in childhood
10.1002/pbc.20676 · 2006 · External reference
Humidifier disinfectant-associated children’s interstitial lung disease: computed tomographic features, histopathologic correlation and comparison between survivors and non-survivors
10.1007/s00330-015-3813-1 · 2016 · External reference
Transforming growth factor-beta 1 in humidifier disinfectant-associated children’s interstitial lung disease
10.1002/ppul.23226 · 2016 · External reference
Lung involvement in children with lysinuric protein intolerance
10.1007/s10545-014-9777-5 · 2015 · External reference
Systemic juvenile idiopathic arthritis-associated lung disease: characterization and risk factors
10.1002/art.41073 · 2019 · External reference
Lung disease in Niemann-Pick disease
10.1002/ppul.20725 · 2007 · External reference
Evaluation of inter-observer variation for computed tomography identification of childhood interstitial lung disease
10.1183/23120541.00100-2019 · 2019 · External reference
Children’s interstitial lung disease: multidetector computed tomography patterns and correlations between imaging and histopathology
10.1016/j.ejrad.2023.110886 · 2023 · External reference
Medical imaging and pediatric and adolescent hematologic cancer risk
10.1056/nejmoa2502098 · 2025 · External reference
Treatable traits: a comprehensive precision medicine approach in interstitial lung disease
10.1183/13993003.00404-2023 · 2023 · External reference
Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies
10.1097/mcp.0000000000000712 · 2020 · External reference
Open lung biopsy in infants and children
10.1001/archsurg.1971.01350080111017 · 1971 · External reference
Open lung biopsy in children with diffuse lung disease
10.1136/adc.49.1.27 · 1974 · External reference
Pediatric transbronchial lung biopsy
10.1177/000348949210100205 · 1992 · External reference
Diagnosis of interstitial lung disease by a percutaneous lung biopsy sample
10.1136/adc.70.2.143 · 1994 · External reference
Combined percutaneous lung biopsy and high-resolution computed tomography in the diagnosis and management of lung disease in children
10.1002/(sici)1099-0496(199608)22:2<111::aid-ppul6>3.0.co;2-t · 1996 · External reference
Diagnostic value of transbronchial, thoracoscopic, and open lung biopsy in immunocompetent children with chronic interstitial lung disease
10.1016/s0022-3476 · 1997 · External reference
Open lung biopsy for diffuse interstitial lung disease in children
10.1034/j.1399-3003.1999.14d16.x · 1999 · External reference
Thoracoscopic biopsy in children with diffuse parenchymal lung disease
10.1002/ppul.20896 · 2008 · External reference
Diffuse lung disease in infancy and childhood: expanding the chILD classification
10.1111/his.12185 · 2013 · External reference
Lung biopsy for chronic pulmonary disease in children
10.1016/j.jpedsurg.2013.10.026 · 2014 · External reference
Diagnostic accuracy and therapeutic relevance of thoracoscopic lung biopsies in children
10.1002/ppul.23999 · 2018 · External reference
Safety, utility and clinical efficacy of cryobiopsy of lung in paediatric population-a single centre experience
10.4103/lungindia.lungindia_217_23 · 2023 · External reference
Interstitial lung disease in immunocompromised children
10.3390/diagnostics13010064 · 2022 · External reference
Open-lung biopsy guides therapy in children
10.1016/s0003-4975(01)02516-4 · 2001 · External reference
Open lung biopsy in neonatal and paediatric patients referred for extracorporeal membrane oxygenation (ECMO)
10.1136/thx.2003.010793 · 2004 · External reference
Alveolar capillary dysplasia: a six-year single center experience
10.1515/jpm.2005.067 · 2005 · External reference
Diffuse lung disease in infants less than 1 year of age: histopathological diagnoses and clinical outcome
10.1002/ppul.23124 · 2015 · External reference
Analysis of pulmonary features and treatment approaches in the COPA syndrome
10.1183/23120541.00017-2018 · 2018 · External reference
A safe and minimally invasive method for thoracoscopic lung biopsy in interstitial lung disease
10.1089/ped.2019.1044 · 2019 · External reference
Morbidity and mortality of open lung biopsy in children
10.1542/peds.99.5.660 · 1997 · External reference
Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies
10.2350/08-11-0559.1 · 2009 · External reference
Evaluation of a diagnostic approach to pediatric interstitial lung disease
10.1542/peds.101.1.82 · 1998 · External reference
Spectrum of childhood interstitial and diffuse lung diseases at a tertiary hospital in Egypt
10.1183/23120541.00880-2020 · 2021 · External reference
Risk and relevance of open lung biopsy in pediatric ECMO patients: the Dutch experience
10.1016/j.jpedsurg.2016.11.031 · 2017 · External reference
Open lung biopsy in pediatric patients on extracorporeal membrane oxygenation
10.1016/s0022-3468(96)90832-5 · 1996 · External reference
Is thoracoscopy superior to thoracotomy in the treatment of congenital lung malformations? An updated meta-analysis
10.1177/1753466620980267 · 2020 · External reference
Lung biopsy in the diagnosis and management of chILD
10.1002/ppul.26454 · 2024 · External reference
Perioperative complications of video-assisted thoracoscopic pulmonary procedures in neonates and infants
10.1055/s-0038-1636917 · 2018 · External reference
Procedure volume and mortality after surgical lung biopsy in interstitial lung disease
10.1183/13993003.01164-2018 · 2019 · External reference
Intraoperative chest tube removal following thoracoscopic lung biopsy results in improved outcomes
10.1016/j.jpedsurg.2014.04.008 · 2014 · External reference
An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease
10.1183/13993003.00639-2024 · 2024 · External reference
Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation
10.1016/j.healun.2021.07.005 · 2021 · External reference
International Society for Heart and Lung Transplantation consensus statement on the referral and selection of pediatric lung transplant candidates
10.1016/j.healun.2025.08.005 · 2025 · External reference
Improved outcomes of infant lung transplantation over 3 decades
10.1016/j.athoracsur.2021.04.032 · 2022 · External reference
Lung transplantation in children and young adults: a 20-year single-centre experience
10.1183/09031936.00092211 · 2012 · External reference
The international thoracic organ transplant registry of the international society for heart and lung transplantation: twenty-fifth pediatric lung transplantation report—2022; focus on pulmonary vascular diseases
10.1016/j.healun.2022.07.020 · 2022 · External reference
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-fourth pediatric lung transplantation report—2021; focus on recipient characteristics
10.1016/j.healun.2021.07.018 · 2021 · External reference
Poor functional status at the time of waitlist for pediatric lung transplant is associated with worse pretransplant outcomes
10.1016/j.healun.2023.07.003 · 2023 · External reference
Lung transplantation in children
10.1097/00000658-200209000-00003 · 2002 · External reference
A shifting landscape: practice patterns and outcomes of cystic fibrosis and non-cystic fibrosis pediatric lung transplantation
10.1111/petr.14086 · 2021 · External reference
Outcome of infants listed for lung or heart/lung transplantation
10.1016/s1053-2498(99)00087-x · 1999 · External reference
Favorable outcome of children and adolescents undergoing lung transplantation at a European adult center in the new era
10.1002/ppul.23383 · 2016 · External reference
Pediatric lung transplantation at St. Louis Children’s Hospital, 1990-1995
10.1164/ajrccm.155.3.9116982 · 1997 · External reference
Mortality after lung transplantation for children bridged with extracorporeal membrane oxygenation
10.1513/annalsats.202103-250oc · 2022 · External reference
Two decades of pediatric lung transplant in the United States: have we improved?
10.1016/j.jtcvs.2010.06.067 · 2011 · External reference
Improved outcomes for infants and young children undergoing lung transplantation at three years of age and younger
10.1513/annalsats.202202-093oc · 2023 · External reference
Lung transplantation for FLNA-associated progressive lung disease
10.1016/j.jpeds.2017.03.045 · 2017 · External reference
Lung transplantation in infants and toddlers from 1990 to 2004 at St. Louis Children’s Hospital
10.1111/j.1600-6143.2009.02552.x · 2009 · External reference
Is lung transplantation survival better in infants? Analysis of over 80 infants
10.1016/j.healun.2012.09.027 · 2013 · External reference
Bronchial airway anastomotic complications after pediatric lung transplantation: incidence, cause, management, and outcome
10.1016/j.jtcvs.2005.06.053 · 2006 · External reference
Histopathologic and genetic features of alveolar capillary dysplasia with atypical late presentation and prolonged survival
10.1016/j.jpeds.2019.01.047 · 2019 · External reference
Treatable traits in interstitial lung disease: opportunities and challenges
10.1016/j.rmed.2025.108353 · 2025 · External reference
Treatable traits in interstitial lung disease: a narrative review
10.1177/17534666251335774 · 2025 · External reference
Estimating the effect of nintedanib on forced vital capacity in children and adolescents with fibrosing interstitial lung disease using a Bayesian dynamic borrowing approach
10.1002/ppul.26882 · 2024 · External reference
Computed tomographic findings in TBX4 mutation: a common cause of severe pulmonary artery hypertension in children
10.1007/s00247-023-05848-7 · 2024 · External reference
Factors influencing survival in children with chronic interstitial lung disease
10.1164/ajrccm.156.3.9703051 · 1997 · External reference
